Related Experiment Video
Updated: Jul 4, 2026

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
GPCR signalling in hypertension: role of GRKs
David M Harris1, Heather I Cohn, Stéphanie Pesant
1Eugene Feiner Laboratory for Vascular Biology and Thrombosis, Center for Translational Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Insights
Hypertension, or high blood pressure, is linked to elevated levels of GPCR kinases (GRKs). These GRKs play a crucial role in regulating G-protein-coupled receptors (GPCRs), impacting blood pressure control.
Area of Science:
- Cardiovascular Physiology
- Molecular Biology
- Pharmacology
Background:
- Hypertension affects 30% of US adults, increasing cardiovascular complication risk.
- Elevated blood pressure leads to afterload increase and potential congestive heart failure.
- Current hypertension medications are insufficient, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review the role of GPCR kinases (GRKs) in hypertension.
- To explore how GRKs regulate G-protein-coupled receptors (GPCRs) in blood pressure control.
- To highlight the association of GRK2 and GRK5 with hypertension.
Main Methods:
- Review of existing literature on GRKs, GPCRs, and hypertension.
- Analysis of the role of GRK2 and GRK5 in vascular smooth muscle (VSM) and lymphocytes.
- Examination of hormonal and peptide regulation of blood pressure via GPCR signaling.
Main Results:
- Elevated GRK2 or GRK5 levels are observed in human hypertension and animal models.
- GRKs are critical regulators of GPCR signaling pathways involved in blood pressure.
- Hormones like angiotensin II (AngII) and catecholamines, acting through GPCRs, are implicated in hypertension.
Conclusions:
- GRKs are key players in the pathogenesis of hypertension.
- Targeting GRK-GPCR interactions may offer new therapeutic avenues for managing high blood pressure.
- Understanding GRK regulation of GPCRs is essential for developing effective hypertension treatments.
Abstract:
Hypertension is a prevalent condition in the developed world and disease severity is directly correlated with additional cardiovascular complications. It is estimated that 30% of the adult population in the United States has hypertension, which is classified as a systolic blood pressure > or =140 mmHg and/or a diastolic blood pressure > or =90 mmHg. A prolonged increase in afterload ultimately leads to congestive heart failure in the majority of cases. Currently, medication designed to treat hypertension is inadequate, thus new therapies need to be explored. Blood pressure is tightly regulated by blood vessel radius, which is established by hormones and/or peptides binding to GPCRs (G-protein-coupled receptors). Catecholamines and peptide hormones, such as AngII (angiotensin II), are elevated in hypertension and, therefore, signalling by these GPCRs is increased. Their signalling is tightly controlled by a class of proteins, the GRKs (GPCR kinases). Elevated levels of either GRK2 or GRK5 in both the lymphocytes and VSM (vascular smooth muscle) are associated with human hypertension and animal models of the disease. The focus of the present review is on the role GRKs, and their regulation of GPCRs, play in high blood pressure.
Related Concept Videos
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity
Two...
Amplifying Signals via Enzymatic Cascade
G-Protein Gated Ion Channels
Sensory organs,...
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Hypertension and Regulation of Blood Pressure
